DOCSLIB.ORG

Functionally Related MTOR-Sensitive Mrnas

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Downloaded from genome.cshlp.org on October 3, 2021 - Published by Cold Spring Harbor Laboratory Press 1 nanoCAGE reveals 5’UTR features that define specific modes of translation of 2 functionally related MTOR-sensitive mRNAs 3 Valentina Gandin1,2,3,4*, Laia Masvidal5*, Laura Hulea1,2*, Simon-Pierre Gravel4,6, Marie 4 Cargnello1,2, Shannon McLaughlan1,2, Yutian Cai1,4, Preetika Balanathan7, Masahiro 5 Morita4,6, Arjuna Rajakumar1, Luc Furic7, Michael Pollak1,2,3, John A. Porco, Jr.8, Julie 6 St-Pierre4,6, Jerry Pelletier2,4,6,, Ola Larsson5** and Ivan Topisirovic1,2,3,4** 7 1Lady Davis Institute, SMBD Jewish General Hospital, Montreal, Canada; Departments 8 of 2Oncology, 3Experimental Medicine, and 4Biochemistry McGill University, Montreal, 9 Canada; 5Department of Oncology-Pathology, Science for Life Laboratory, Karolinska 10 Institutet, Stockholm, Sweden; 6Goodman Cancer Research Centre, McGill University, 11 Montreal, Canada; 7Cancer Program, Biomedicine Discovery Institute and Department of 12 Anatomy & Developmental Biology, Monash University, VIC, Australia, 8Center for 13 Chemical Methodology and Library Development, Boston University, 590 14 Commonwealth Avenue, Boston, Massachusetts 02215, United States 15 16 *equally contributing 17 18 Correspondence: Ola Larsson, Department of Oncology-Pathology, Karolinska Institutet 19 Tomtebodavägen 23A, 171 65 Solna Sweden Tel: +46 (0)8 524 81 228; Email: 20 [email protected] & Ivan Topisirovic, Lady Davis Institute for Medical Research, Office 21 E-445; 3755 Côte Ste-Catherine Road, Montreal, Quebec H3T 1E2, Canada; Tel: (514) 22 340-8222 ext 3146; Email: [email protected] 23 Running title: 5’UTR features of MTOR-sensitive mRNAs. 1 Downloaded from genome.cshlp.org on October 3, 2021 - Published by Cold Spring Harbor Laboratory Press 24 Key words: nanoCAGE, mRNA translation, MTOR, EIF4E, EIF4A1 25 Abstract 26 The diversity of MTOR-regulated mRNA translation remains unresolved. Whereas 27 ribosome-profiling suggested that MTOR almost exclusively stimulates translation of 28 TOP (terminal oligopyrimidine motif) and TOP-like mRNAs, polysome-profiling 29 indicated that MTOR also modulates translation of mRNAs without 5’TOP motif (non- 30 TOP mRNAs). We demonstrate that in ribosome-profiling studies detection of MTOR- 31 dependent changes in non-TOP mRNA translation was obscured by low sensitivity and 32 methodology biases. Transcription start site profiling using Nano-Cap Analysis of Gene 33 Expression (nanoCAGE) revealed not only do many MTOR-sensitive mRNAs lack 34 5’TOP motif but that 5’UTR features distinguish two functionally, and translationally 35 distinct subsets of MTOR-sensitive mRNAs: i) mRNAs with short 5’UTR enriched for 36 mitochondrial functions, that require EIF4E, but are less EIF4A1-sensitive and ii) long 37 5’UTRs mRNAs encoding proliferation- and survival-promoting proteins, that are both 38 EIF4E- and EIF4A1-sensitive. Selective inhibition of translation of mRNAs harboring 39 long 5’UTRs via EIF4A1 suppression leads to sustained expression of proteins involved 40 in respiration but concomitant loss of those protecting mitochondrial structural integrity, 41 resulting in apoptosis. Conversely, simultaneous suppression of translation of both long 42 and short 5’UTR mRNAs, by MTOR inhibitors, results in metabolic dormancy and a 43 predominantly cytostatic effect. Thus, 5’UTR features define different modes of MTOR- 44 sensitive translation of functionally distinct subsets of mRNAs which may explain the 45 diverse impact of MTOR and EIF4A inhibitors on neoplastic cells. 46 47 48 49 50 51 2 Downloaded from genome.cshlp.org on October 3, 2021 - Published by Cold Spring Harbor Laboratory Press 52 Introduction: 53 Genome-wide gene expression studies have mostly focused on measuring ‘steady-state’ 54 mRNA abundance that reflects alterations in transcription and mRNA stability (Piccirillo 55 et al. 2014). Changes in steady-state mRNA abundance do not, however, completely 56 mirror those occurring in the corresponding proteome (Gygi et al. 1999; de Sousa Abreu 57 et al. 2009; Larsson et al. 2012; Kristensen et al. 2013; Ly et al. 2014). Although still 58 debated (Li and Biggin 2015), these studies implicate post-transcriptional mechanisms, 59 including mRNA translation, as key influencers over the proteome (Schwanhausser et al. 60 2011; Vogel and Marcotte 2012; Kristensen et al. 2013; Li et al. 2014; Jovanovic et al. 61 2015). 62 63 Control of translation largely occurs at the initiation step, during which the mRNA is 64 recruited to the ribosome by the eIF4F complex (Hinnebusch 2014). This complex 65 consists of the mRNA cap-binding protein EIF4E, a large scaffolding protein EIF4G and 66 DEAD box helicase EIF4A (Hinnebusch 2014). eIF4F complex assembly is regulated by 67 the mechanistic/mammalian target of rapamycin (mTOR) complex 1 (mTORC1) which 68 phosphorylates and inactivates 4E-binding proteins (EIF4EBP1, 2 and 3) (von Manteuffel 69 et al. 1996; Hara et al. 1997; Burnett et al. 1998; Gingras et al. 1999; Gingras et al. 2001). 70 EIF4EBPs bind to EIF4E thereby preventing EIF4E:EIF4G association (Pause et al. 71 1994a). Phosphorylation of EIF4EBPs leads to their dissociation from EIF4E, allowing 72 EIF4E:EIF4G interaction and eIF4F assembly (Gingras et al. 1999; Gingras et al. 2001). 73 Although EIF4E is required for cap-dependent translation of all nuclear-encoded 74 mRNAs, a subset of mRNAs characterized by long and complex 5’UTRs that encode 3 Downloaded from genome.cshlp.org on October 3, 2021 - Published by Cold Spring Harbor Laboratory Press 75 proliferation- (e.g. cyclins), survival- (e.g. BCL2 family members) and tumor-promoting 76 proteins (e.g. MYC) are thought to be particularly sensitive to EIF4E (Koromilas et al. 77 1992; Graff et al. 2008; Roux and Topisirovic 2012; Pelletier et al. 2015). 78 79 UTR features dictate translation efficiency (Sonenberg and Hinnebusch 2009). In 80 mammals, mRNAs with long, complex 5’UTRs exhibit a high EIF4A helicase 81 requirement for scanning of 43S complex towards the initiation codon (Svitkin et al. 82 2001). EIF4A processivity, as a single protein, is low (Pause et al. 1994b). EIF4A:EIF4G 83 interaction dramatically increases EIF4A processivity (Garcia-Garcia et al. 2015). EIF4E 84 recruits EIF4A to the eIF4F complex thereby bolstering EIF4A activity (Feoktistova et al. 85 2013). Recent ribosome-profiling studies indicate that the mTORC1/EIF4EBP/EIF4E 86 pathway almost exclusively regulates translation of mRNAs harboring 5’ terminal 87 oligopyrimidine (5’TOP) and related motifs (Hsieh et al. 2012; Thoreen et al. 2012). 88 5’TOP motif consists of a C immediately after the mRNA cap followed by 4-to-15 89 pyrimidines (Meyuhas and Kahan 2014). TOP mRNAs encode translational machinery 90 components, including ribosomal proteins and elongation factors (Meyuhas and Kahan 91 2014). 92 93 The generality of the conclusions that EIF4EBPs are major regulators of TOP mRNA 94 translation has been questioned since, under a number of conditions, translation of TOP 95 mRNAs, albeit MTOR-dependent, is EIF4EBP-independent (Miloslavski et al. 2014). 96 Consistent with this view, the effects of serum deprivation on TOP mRNA translation 97 also appeared to be EIF4E-independent (Shama et al. 1995). In turn, LARP1 and 4 Downloaded from genome.cshlp.org on October 3, 2021 - Published by Cold Spring Harbor Laboratory Press 98 TIA1/TIAL1 (also known as TIAR) were reported to mediate effects of mTORC1 on 99 TOP mRNAs (Damgaard and Lykke-Andersen 2011; Tcherkezian et al. 2014; Fonseca et 100 al. 2015). Polysome-profiling showed that the mTORC1/EIF4EBP axis also regulates 101 translation of non-TOP mRNAs, including those encoding mitochondrial and survival- 102 and proliferation-promoting proteins (Larsson et al. 2012; Morita et al. 2013). In fact, it 103 appears that ribosome- and polysome-profiling studies provided strikingly different sets 104 of MTOR-sensitive mRNAs. 105 106 Elucidating the precise mechanisms that control mRNA translation also requires accurate 107 knowledge of transcription start sites (TSS). Despite substantial efforts to define TSS 108 using CAGE/nanoCAGE (Consortium et al. 2014) or TSS-seq (Suzuki and Sugano 2003; 109 Suzuki et al. 2015) there are no resources, which provide TSS information for most 110 commonly used model cell lines. Databases such as RefSeq or UCSC are thus routinely 111 used to infer the link between 5’UTR features and translation. These databases are 112 thought to contain numerous errors and for a more accurate understanding of the 113 relationship between the 5’UTR features and translational control both TSS and 114 translation efficiency should be determined in the same cell. 115 116 Results: 117 Simulating the impact of differences in polysome-association on performance of 118 ribosome- and polysome-profiling 119 We compared ribosome- and polysome-profiling for their ability to identify mRNAs 120 undergoing different shifts in translational efficiency. In polysome-profiling, translation 5 Downloaded from genome.cshlp.org on October 3, 2021 - Published by Cold Spring Harbor Laboratory Press 121 efficiency is directly determined by separating efficiently (commonly defined as mRNAs 122 associated with >3 ribosomes) and not efficiently translated mRNAs (defined as mRNAs 123 associated with 3 or less ribosomes) (Gandin et al. 2014). In contrast, with ribosome- 124 profiling translational efficiency is inferred based on the number of RNA sequencing 125 reads corresponding to ribosome-protected fragments (Gandin et al. 2014; Ingolia 2014; 126 King and Gerber 2014). TOP mRNAs are highly expressed (Fig. 1A-B), engage a 127 considerable proportion of cellular ribosomes when MTOR is active (Levy et al. 1991; 128 Meyuhas and Kahan 2014; Miloslavski et al. 2014) and show large shifts in translational 129 efficiency upon MTOR inhibition, as compared to mRNAs that do not contain 5’TOP 130 motif [non-TOP mRNAs; Sup. Fig. 1 (Levy et al. 1991; Miloslavski et al. 2014)]. 131 132 We next determined performance of ribosome- vs. polysome-profiling in identifying 133 differentially translated mRNAs as a function of the size of shifts in translational 134 efficiency using simulation approach.
Recommended publications
  • A Helicase-Independent Activity of Eif4a in Promoting Mrna Recruitment to the Human Ribosome

    A Helicase-Independent Activity of Eif4a in Promoting Mrna Recruitment to the Human Ribosome

    A helicase-independent activity of eIF4A in promoting mRNA recruitment to the human ribosome Masaaki Sokabea and Christopher S. Frasera,1 aDepartment of Molecular and Cellular Biology, College of Biological Sciences, University of California, Davis, CA 95616 Edited by Alan G. Hinnebusch, National Institutes of Health, Bethesda, MD, and approved May 5, 2017 (received for review December 12, 2016) In the scanning model of translation initiation, the decoding site and at the solvent side of the mRNA entry channel (14). Importantly, latch of the 40S subunit must open to allow the recruitment and that study showed that a short mRNA that does not extend into the migration of messenger RNA (mRNA); however, the precise molec- entry channel fails to displace eIF3j. A similar observation was also ular details for how initiation factors regulate mRNA accommodation found for initiation mediated by the hepatitis C virus internal ribo- into the decoding site have not yet been elucidated. Eukaryotic some entry site, where an mRNA truncated after the initiation co- initiation factor (eIF) 3j is a subunit of eIF3 that binds to the mRNA don failed to displace eIF3j (11). Taken together, these studies entry channel and A-site of the 40S subunit. Previous studies have suggest a model in which a full accommodation of mRNA in the shown that a reduced affinity of eIF3j for the 43S preinitiation mRNA entry channel of the 40S subunit corresponds to a reduced complex (PIC) occurs on eIF4F-dependent mRNA recruitment. Because affinity of eIF3j for the 40S subunit. This model has allowed us to eIF3j and mRNA bind anticooperatively to the 43S PIC, reduced eIF3j exploit the change in eIF3j affinity for the 43S PIC to quantitatively affinity likely reflects a state of full accommodation of mRNA into the monitor the process of mRNA recruitment.
  • Accumulation of Dephosphorylated 4EBP After Mtor Inhibition with Rapamycin Is Sufficient to Disrupt Paracrine Transformation By

    Accumulation of Dephosphorylated 4EBP After Mtor Inhibition with Rapamycin Is Sufficient to Disrupt Paracrine Transformation By

    Oncogene (2014) 33, 2405–2412 & 2014 Macmillan Publishers Limited All rights reserved 0950-9232/14 www.nature.com/onc SHORT COMMUNICATION Accumulation of dephosphorylated 4EBP after mTOR inhibition with rapamycin is sufficient to disrupt paracrine transformation by the KSHV vGPCR oncogene D Martin, Q Nguyen, A Molinolo and JS Gutkind Dysregulation of the PI3K/Akt/mTOR pathway is one of the most frequent events in human cancer. However, the clinical benefits of PI3K/Akt/mTOR inhibitors have not yet achieved their predicted potential in many of the most prevalent human cancers. Of interest, treatment of Kaposi’s sarcoma (KS) patients with rapamycin provided the first evidence of the antineoplastic activity of mTOR inhibitors in humans, becoming the standard of care for KS arising in renal transplant patients. Thus, the study of KS may provide a unique opportunity to dissect the contribution of specific mTOR downstream targets to cancer development. The KS- associated herpesvirus (KSHV) is the etiological agent for KS, and the KSHV-encoded oncogene viral-G protein-coupled receptor (vGPCR) promotes the potent activation of the PI3K-Akt-mTOR pathway by both direct and paracrine mechanisms. We focused on a direct target of mTOR, EIF4EBP1/2/3 (4EBP), which inhibits the translation of eukaryotic initiation factor 4E (eiF4E)-bound mRNAs. 4EBP phosphorylation by mTOR relieves its inhibitory activity, hence resulting in increased eiF4E-dependent mRNA translation. We developed a paracrine transformation model, recapitulating the cellular composition of KS lesions, in which vGPCR-expressing cells promote the rapid proliferation of endothelial cells, thus expressing KSHV-latent genes by the release of growth factors.
  • Adaptive Capabilities of the Pi3k/Akt/Mtor Pathway in Acute Myeloid Leukemia Revealed by the Use of Selective Inhibitors

    Adaptive Capabilities of the Pi3k/Akt/Mtor Pathway in Acute Myeloid Leukemia Revealed by the Use of Selective Inhibitors

    Alma Mater Studiorum – Università di Bologna SCIENZE BIOMEDICHE: PROGETTO 5 “SCIENZE MORFOLOGICHE UMANE E MOLECOLARI” Ciclo XXV SSD : BIO 16, SETTORE CONCORSUALE :05H1 ADAPTIVE CAPABILITIES OF THE PI3K/AKT/MTOR PATHWAY IN ACUTE MYELOID LEUKEMIA REVEALED BY THE USE OF SELECTIVE INHIBITORS Presentata da Jessika Bertacchini Relatori Prof.ssa Lucia Manzoli Prof.ssa Sandra Marmiroli Coordinatore Chiar. mo Prof. Lucio Cocco TABLE OF CONTENTS o ABSTRACT o INTRODUCTION o ACUTE MYELOID LEUKEMIA o PROGNOSIS AND GENETICS o DEREGULATED SIGNAL TRANSDUCTION PATHWAYS IN ACUTE MYELOID LEUKEMIA o PI3K/AKT/MTOR SIGNAL TRANSDUCTION PATHWAY IN ACUTE MYELOID LEUKEMIA o PI3K o AKT/PKB o Mtor o NEGATIVE REGULATION OF PI3K/AKT/mTOR PATHWAY o PI3K/AKT/mTOR PATHWAY AND SURVIVAL o PI3K/AKT/mTOR PATHWAY AND CELL CYCLE o PI3K/AKT/mTOR PATHWAY AND METABOLISM o PI3K/AKT/mTOR INHIBITORS o PI3K INHIBITORS o AKT INHIBITORS o mTOR INHIBITORS o TYROSINE KINASE RECEPTOR o TYROSINE KINASE RECEPTOR IN ACUTE MYELOID LEUKEMIA o AIMS o MATERIALS AND METHODS o PATIENTS DEMOGRAPHICS o CELL CULTURE AND DRUG TREATMENTS o ARRAY ASSEMBLY o RESULTS o RESULTS o DISCUSSION o BIBLIOGRA 1.ABSTRACT The objective of the study was to investigate the sensitivity of primary blasts from AML patients to PI3K/Akt/mTor inhibitors through reverse-phase protein microarray. Reverse-phase microarray assays using phosphospecific antibodies (RPPA) can directly measure levels of phosphorylated protein isoforms. Mapping of deregulated kinases and protein signaling networks within tumors can provide a means to stratify patients with shared biological characteristics to the most optimal treatment, and identify drug targets. In particular, the PI3K/AKT/mTOR signaling pathways are frequently activated in blast cells from patients with acute myelogenous leukemia (AML), a neoplastic disorder characterized by the accumulation of genetically altered myelogenous cells displaying deregulated intracellular signalling pathways and aggressive clinical behavior with poor prognosis.
  • Ten Commandments for a Good Scientist

    Ten Commandments for a Good Scientist

    Unravelling the mechanism of differential biological responses induced by food-borne xeno- and phyto-estrogenic compounds Ana María Sotoca Covaleda Wageningen 2010 Thesis committee Thesis supervisors Prof. dr. ir. Ivonne M.C.M. Rietjens Professor of Toxicology Wageningen University Prof. dr. Albertinka J. Murk Personal chair at the sub-department of Toxicology Wageningen University Thesis co-supervisor Dr. ir. Jacques J.M. Vervoort Associate professor at the Laboratory of Biochemistry Wageningen University Other members Prof. dr. Michael R. Muller, Wageningen University Prof. dr. ir. Huub F.J. Savelkoul, Wageningen University Prof. dr. Everardus J. van Zoelen, Radboud University Nijmegen Dr. ir. Toine F.H. Bovee, RIKILT, Wageningen This research was conducted under the auspices of the Graduate School VLAG Unravelling the mechanism of differential biological responses induced by food-borne xeno- and phyto-estrogenic compounds Ana María Sotoca Covaleda Thesis submitted in fulfillment of the requirements for the degree of doctor at Wageningen University by the authority of the Rector Magnificus Prof. dr. M.J. Kropff, in the presence of the Thesis Committee appointed by the Academic Board to be defended in public on Tuesday 14 September 2010 at 4 p.m. in the Aula Unravelling the mechanism of differential biological responses induced by food-borne xeno- and phyto-estrogenic compounds. Ana María Sotoca Covaleda Thesis Wageningen University, Wageningen, The Netherlands, 2010, With references, and with summary in Dutch. ISBN: 978-90-8585-707-5 “Caminante no hay camino, se hace camino al andar. Al andar se hace camino, y al volver la vista atrás se ve la senda que nunca se ha de volver a pisar” - Antonio Machado – A mi madre.
  • Initiation Factor Eif5b Catalyzes Second GTP-Dependent Step in Eukaryotic Translation Initiation

    Initiation Factor Eif5b Catalyzes Second GTP-Dependent Step in Eukaryotic Translation Initiation

    Initiation factor eIF5B catalyzes second GTP-dependent step in eukaryotic translation initiation Joon H. Lee*†, Tatyana V. Pestova†‡§, Byung-Sik Shin*, Chune Cao*, Sang K. Choi*, and Thomas E. Dever*¶ *Laboratory of Gene Regulation and Development, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892-2716; ‡Department of Microbiology and Immunology, State University of New York Health Science Center, Brooklyn, NY 11203; and §A. N. Belozersky Institute of Physico-Chemical Biology, Moscow State University, Moscow, Russia Edited by Harry F. Noller, University of California, Santa Cruz, CA, and approved October 31, 2002 (received for review September 19, 2002) Initiation factors IF2 in bacteria and eIF2 in eukaryotes are GTPases In addition, when nonhydrolyzable GDPNP was substituted Met that bind Met-tRNAi to the small ribosomal subunit. eIF5B, the for GTP, eIF5B catalyzed subunit joining; however, the factor eukaryotic ortholog of IF2, is a GTPase that promotes ribosomal was unable to dissociate from the 80S ribosome after subunit subunit joining. Here we show that eIF5B GTPase activity is re- joining (7). quired for protein synthesis. Mutation of the conserved Asp-759 in To dissect the function of the eIF5B G domain and test the human eIF5B GTP-binding domain to Asn converts eIF5B to an model that two GTP molecules are required in translation XTPase and introduces an XTP requirement for subunit joining and initiation, we mutated conserved residues in the eIF5B G translation initiation. Thus, in contrast to bacteria where the single domain and tested the function of the mutant proteins in GTPase IF2 is sufficient to catalyze translation initiation, eukaryotic translation initiation.
  • Comparative Mapping of Bovine Chromosome 27 with Human Chromosome 8 Near a Dairy Form QTL in Cattle

    Comparative Mapping of Bovine Chromosome 27 with Human Chromosome 8 Near a Dairy Form QTL in Cattle

    University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln U.S. Department of Agriculture: Agricultural Publications from USDA-ARS / UNL Faculty Research Service, Lincoln, Nebraska 2006 Comparative mapping of bovine chromosome 27 with human chromosome 8 near a dairy form QTL in cattle E. E. Connor USDA-ARS M. S. Ashwell North Carolina State University at Raleigh R. Schnabel University of Missouri-Columbia J. L. Williams Roslin Institute (Edinburgh) Follow this and additional works at: https://digitalcommons.unl.edu/usdaarsfacpub Part of the Agricultural Science Commons Connor, E. E.; Ashwell, M. S.; Schnabel, R.; and Williams, J. L., "Comparative mapping of bovine chromosome 27 with human chromosome 8 near a dairy form QTL in cattle" (2006). Publications from USDA-ARS / UNL Faculty. 698. https://digitalcommons.unl.edu/usdaarsfacpub/698 This Article is brought to you for free and open access by the U.S. Department of Agriculture: Agricultural Research Service, Lincoln, Nebraska at DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Publications from USDA-ARS / UNL Faculty by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln. Original Article Cytogenet Genome Res 112:98–102 (2006) DOI: 10.1159/000087519 Comparative mapping of bovine chromosome 27 with human chromosome 8 near a dairy form QTL in cattle E.E. Connor,a M.S. Ashwell,a,b R. Schnabel,c J.L. Williamsd a Beltsville Agricultural Research Center, ARS, USDA, Beltsville, MD; b North Carolina State University, Department of Animal Science, Raleigh, NC; c University of Missouri-Columbia, Animal Sciences Unit, Columbia, MO (USA); d Roslin Institute (Edinburgh), Roslin, Midlothian, Scotland (UK) Manuscript received 30 December 2004; accepted in revised form for publication by T.
  • Eif4a Is Stimulated by the Pre-Initiation Complex and Enhances Recruitment of Mrnas Regardless of Structural Complexity

    Eif4a Is Stimulated by the Pre-Initiation Complex and Enhances Recruitment of Mrnas Regardless of Structural Complexity

    bioRxiv preprint doi: https://doi.org/10.1101/147959; this version posted June 13, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 1 eIF4A is stimulated by the pre-initiation complex and enhances recruitment of mRNAs regardless of structural 2 complexity 3 Paul Yourik1, Colin Echeverría Aitken1, Fujun Zhou1, Neha Gupta1,2, Alan G. Hinnebusch2,3, Jon R. Lorsch1,3 4 5 1Laboratory on the Mechanism and Regulation of Protein Synthesis, Eunice Kennedy Shriver National Institute of Child 6 Health and Development, National Institutes of Health, Bethesda, MD 20892 7 2Laboratory of Gene Regulation and Development, Eunice Kennedy Shriver National Institute of Child Health and 8 Human Development, National Institutes of Health, Bethesda, MD 20892, USA 9 3Corresponding Author 10 11 ABSTRACT 12 eIF4A is a DEAD-box RNA-dependent ATPase thought to unwind RNA secondary structure in the 5'-untranslated 13 regions (UTRs) of mRNAs to promote their recruitment to the eukaryotic translation pre-initiation complex (PIC). We 14 show that the PIC stimulates the ATPase of eIF4A, indicating that the factor acts in association with initiating ribosomal 15 complexes rather than exclusively on isolated mRNAs. ATP hydrolysis by eIF4A accelerates the rate of recruitment for 16 all mRNAs tested, regardless of their degree of secondary structure, indicating that the factor plays important roles 17 beyond unwinding mRNA structure. Structures in the 5'-UTR and 3' of the start codon synergistically inhibit mRNA 18 recruitment, in a manner relieved by eIF4A, suggesting that the factor resolves global mRNA structure rather than just 19 secondary structures in the 5'-UTR.
  • Whole Exome Sequencing in Families at High Risk for Hodgkin Lymphoma: Identification of a Predisposing Mutation in the KDR Gene

    Whole Exome Sequencing in Families at High Risk for Hodgkin Lymphoma: Identification of a Predisposing Mutation in the KDR Gene

    Hodgkin Lymphoma SUPPLEMENTARY APPENDIX Whole exome sequencing in families at high risk for Hodgkin lymphoma: identification of a predisposing mutation in the KDR gene Melissa Rotunno, 1 Mary L. McMaster, 1 Joseph Boland, 2 Sara Bass, 2 Xijun Zhang, 2 Laurie Burdett, 2 Belynda Hicks, 2 Sarangan Ravichandran, 3 Brian T. Luke, 3 Meredith Yeager, 2 Laura Fontaine, 4 Paula L. Hyland, 1 Alisa M. Goldstein, 1 NCI DCEG Cancer Sequencing Working Group, NCI DCEG Cancer Genomics Research Laboratory, Stephen J. Chanock, 5 Neil E. Caporaso, 1 Margaret A. Tucker, 6 and Lynn R. Goldin 1 1Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD; 2Cancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD; 3Ad - vanced Biomedical Computing Center, Leidos Biomedical Research Inc.; Frederick National Laboratory for Cancer Research, Frederick, MD; 4Westat, Inc., Rockville MD; 5Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD; and 6Human Genetics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA ©2016 Ferrata Storti Foundation. This is an open-access paper. doi:10.3324/haematol.2015.135475 Received: August 19, 2015. Accepted: January 7, 2016. Pre-published: June 13, 2016. Correspondence: [email protected] Supplemental Author Information: NCI DCEG Cancer Sequencing Working Group: Mark H. Greene, Allan Hildesheim, Nan Hu, Maria Theresa Landi, Jennifer Loud, Phuong Mai, Lisa Mirabello, Lindsay Morton, Dilys Parry, Anand Pathak, Douglas R. Stewart, Philip R. Taylor, Geoffrey S. Tobias, Xiaohong R. Yang, Guoqin Yu NCI DCEG Cancer Genomics Research Laboratory: Salma Chowdhury, Michael Cullen, Casey Dagnall, Herbert Higson, Amy A.
  • Human 4E-BP1 / EIF4EBP1 Protein (His Tag)

    Human 4E-BP1 / EIF4EBP1 Protein (His Tag)

    Human 4E-BP1 / EIF4EBP1 Protein (His Tag) Catalog Number: 10022-H07E General Information SDS-PAGE: Gene Name Synonym: 4E-BP1; 4EBP1; BP-1; PHAS-I Protein Construction: A DNA sequence encoding the human 4EBP1 (NP_004086.1) (Ser 2-Ile 118) with a N-terminal polyhistidine tag was expressed. Source: Human Expression Host: E. coli QC Testing Purity: > 90 % as determined by SDS-PAGE Endotoxin: Protein Description Please contact us for more information. The translational suppressor eIF4E binding protein-1, 4E-BP1 functions as Stability: a key regulator in cellular growth, differentiation, apoptosis and survival. The Eif4ebp1 gene, encoding 4E-BP1, is a direct target of a transcription Samples are stable for up to twelve months from date of receipt at -70 ℃ factor activating transcription factor-4 (ATF4), a master regulator of gene expression in stress responses. 4E-BP1 is characterized by its capacity to Predicted N terminal: Met bind specifically to eIF4E and inhibit its interaction with eIF4G. Molecular Mass: Phosphorylation of 4E-BP1 regulates eIF4E availability, and therefore, cap- dependent translation, in cell stress. Binding of eIF4E to eIF4G is inhibited The secreted recombinant human 4EBP1 comprises 124 amino acids with in a competitive manner by 4E-BP1. Phosphorylation of 4E-BP1 decreases a predicted molecular mass of 13.4 kDa. It migrates as an approximately the affinity of this protein for eIF4E, thus favouring the binding of eIF4G 19 kDa band in SDS-PAGE under reducing conditions. and enhancing translation. 4E-BP1 is important for beta-cell survival under endoplasmic reticulum (ER) stress. 4E-BP1 mediates the regulation of Formulation: protein translation by hormones, growth factors and other stimuli that signal through the MAP kinase and mTORC1 pathways.
  • Rps3/Us3 Promotes Mrna Binding at the 40S Ribosome Entry Channel and Stabilizes Preinitiation Complexes at Start Codons

    Rps3/Us3 Promotes Mrna Binding at the 40S Ribosome Entry Channel and Stabilizes Preinitiation Complexes at Start Codons

    Rps3/uS3 promotes mRNA binding at the 40S ribosome entry channel and stabilizes preinitiation complexes at start codons Jinsheng Donga, Colin Echeverría Aitkenb, Anil Thakura, Byung-Sik Shina, Jon R. Lorschb,1, and Alan G. Hinnebuscha,1 aLaboratory of Gene Regulation and Development, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892; and bLaboratory on the Mechanism and Regulation of Protein Synthesis, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892 Contributed by Alan G. Hinnebusch, January 24, 2017 (sent for review December 15, 2016; reviewed by Jamie H. D. Cate and Matthew S. Sachs) Met The eukaryotic 43S preinitiation complex (PIC) bearing Met-tRNAi rearrangement to PIN at both near-cognate start codons (e.g., in a ternary complex (TC) with eukaryotic initiation factor (eIF)2-GTP UUG) and cognate (AUG) codons in poor Kozak context; hence scans the mRNA leader for an AUG codon in favorable “Kozak” eIF1 must dissociate from the 40S subunit for start-codon rec- context. AUG recognition provokes rearrangement from an open ognition (Fig. 1A). Consistent with this, structural analyses of PIC conformation with TC bound in a state not fully engaged with partial PICs reveal that eIF1 and eIF1A promote rotation of the “ ” the P site ( POUT ) to a closed, arrested conformation with TC tightly 40S head relative to the body (2, 3), thought to be instrumental bound in the “P ” state. Yeast ribosomal protein Rps3/uS3 resides IN in TC binding in the POUT conformation, but that eIF1 physically in the mRNA entry channel of the 40S subunit and contacts mRNA Met clashes with Met-tRNAi in the PIN state (2, 4), and is both via conserved residues whose functional importance was unknown.
  • Relevance of Translation Initiation in Diffuse Glioma Biology and Its

    Relevance of Translation Initiation in Diffuse Glioma Biology and Its

    cells Review Relevance of Translation Initiation in Diffuse Glioma Biology and its Therapeutic Potential Digregorio Marina 1, Lombard Arnaud 1,2, Lumapat Paul Noel 1, Scholtes Felix 1,2, Rogister Bernard 1,3 and Coppieters Natacha 1,* 1 Laboratory of Nervous System Disorders and Therapy, GIGA-Neurosciences Research Centre, University of Liège, 4000 Liège, Belgium; [email protected] (D.M.); [email protected] (L.A.); [email protected] (L.P.N.); [email protected] (S.F.); [email protected] (R.B.) 2 Department of Neurosurgery, CHU of Liège, 4000 Liège, Belgium 3 Department of Neurology, CHU of Liège, 4000 Liège, Belgium * Correspondence: [email protected] Received: 18 October 2019; Accepted: 26 November 2019; Published: 29 November 2019 Abstract: Cancer cells are continually exposed to environmental stressors forcing them to adapt their protein production to survive. The translational machinery can be recruited by malignant cells to synthesize proteins required to promote their survival, even in times of high physiological and pathological stress. This phenomenon has been described in several cancers including in gliomas. Abnormal regulation of translation has encouraged the development of new therapeutics targeting the protein synthesis pathway. This approach could be meaningful for glioma given the fact that the median survival following diagnosis of the highest grade of glioma remains short despite current therapy. The identification of new targets for the development of novel therapeutics is therefore needed in order to improve this devastating overall survival rate. This review discusses current literature on translation in gliomas with a focus on the initiation step covering both the cap-dependent and cap-independent modes of initiation.
  • DATASHEET Eukaryotic Translation Initiation Factor 4E-Binding

    DATASHEET Eukaryotic Translation Initiation Factor 4E-Binding

    DATASHEET Abbexa Ltd, Innovation Centre, Cambridge Science Park, Cambridge, CB4 0EY, UK Telephone: +44 (0) 1223 755950 - Fax: +44 (0) 1223 755951 - E-Mail: [email protected] Eukaryotic Translation Initiation Factor 4E-Binding Protein 1 (4EBP1) Antibody Catalogue No.:abx015717 Western blot analysis using 4E-BP1 antibody against truncated 4E-BP1 recombinant protein (1) and A431 cell lysate (2). Immunohistochemical analysis of paraffin-embedded human pancreas carcinoma (A), esophagus carcinoma tissue (B) and ovary tumor tissue (C), showing cytoplasmic and membrane localization using 4E-BP1 antibody with DAB staining. 4E-BP1 (eukaryotic translation Initiation Factor 4E Binding Protein 1),also called ELF4EBP1/BP-1/PHAS-I,which is located on chromosome 8p12, with 118-amino acid protein (about 13kDa).Binding of eIF4EBP1 to eIF4E is reversible and is dependent on the phosphorylation status of eIF4EBP1.Non phosphorylated eIF4EBP1 will bind strongly to eIF4E while (24kDa), the phosphorylated form will not.Akt, TOR, MAP kinase, S6 kinase, and Cdc2 are known kinases capable of inactivating eIF4EBP1 binding to eIF4E by phosphorylating either threonines 35, 45, 69 or serine 64.Although, not all phosphorylation events equally block the eIF4EBP1-eIF4E interaction. Target: 4EBP1 Reactivity: Human Host: Mouse Clonality: Monoclonal Tested Applications: ELISA, WB, IHC Recommended dilutions: ELISA: 1/10000, WB: 1/500 - 1/2000, IHC: 1/200 - 1/1000. Optimal dilutions/concentrations should be determined by the end user. Immunogen: Purified recombinant fragment of 4E-BP1 expressed in E. coli. Purification: Unpurified Ascites. Registered in England: 8475531 - VAT Reg No: GB 167 9240 79 Page 1 DATASHEET Abbexa Ltd, Innovation Centre, Cambridge Science Park, Cambridge, CB4 0EY, UK Telephone: +44 (0) 1223 755950 - Fax: +44 (0) 1223 755951 - E-Mail: [email protected] Isotype: IgG1 Conjugation: Unconjugated Storage: Aliquot and store at -20 °C.